FOXP4 and Familial prostate cancer: An experimental study demonstrated that by sequestering miR-3184-5p to upregulate FOXP4-AS1, high expression of FOXP4-AS1 boosted cell proliferation and inhibited apoptosis, demonstrating an oncogenic effect in prostate cancer [19].